ProQR Therapeutics N.V. (NASDAQ: PRQR) reported Q1 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $4.45 million versus the consensus estimate of $3.14 million.

For earnings history and earnings-related data on ProQR Therapeutics N.V. (PRQR) click here.